Comments

MoonLake Stock Price, Quotes and Forecasts

Q: What sector and industry does MoonLake (MLTX) operate in?

MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MLTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

MoonLake (MLTX) Forecast

News Earnings MoonLake (MLTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

MoonLake Stock Price, Quotes and Forecasts | NASDAQ:MLTX | Benzinga

Explore MoonLake stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MLTX.

Open	$36.00
Close	-
Volume / Avg.	61.26K / 445.15K
Day Range	$35.71 - $37.32
52 Wk Range	35.39 - 58.26
Market Cap	$2.35B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	27.61%
Days to Cover	23.37

Recent News

This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Avi Kapoor

Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today?

Results with MoonLake Immunotherapeutics' Nanobody sonelokimab in Psoriatic Arthritis. Achieve over 60% ACR50, 40% ACR70, and 80% PASI90 by week 24. Unprecedented improvements compared to competitors.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$36.00
Close	-
Volume / Avg.	61.26K / 445.15K
Day Range	$35.71 - $37.32
52 Wk Range	35.39 - 58.26
Market Cap	$2.35B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	27.61%
Days to Cover	23.37

About MoonLake Immunotherapeutics

Sector

Health Care

Industry

Biotechnology

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MoonLake (MLTX) stock?

You can purchase shares of MoonLake (NASDAQ:MLTX) through any online brokerage.

View our list of the best stock brokerages

Who are MoonLake (MLTX) competitors?

Other companies in MoonLake’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ascentage Pharma Group (NASDAQ:AAPG), Arcutis Biotherapeutics (NASDAQ:ARQT) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for MoonLake (MLTX) stock?

MoonLake has a consensus price target of $65.79.

What is the current price for MoonLake (MLTX)?

The stock price for MoonLake (NASDAQ: MLTX) is $37.16 last updated April 3, 2025 at 10:40 AM EDT.

Does MoonLake (MLTX) pay a dividend?

There are no upcoming dividends for MoonLake.

When is MoonLake (NASDAQ:MLTX) reporting earnings?

MoonLake’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is MoonLake (MLTX) going to split?

There is no upcoming split for MoonLake.

What sector and industry does MoonLake (MLTX) operate in?

MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.